I find it strange why our trials just don’t have an endpoint of increasing PD-L1 level sufficiently for ICI’s to be used. That way we wouldn’t have to wait a year or two for trial completion.
Cytodyn doesn’t need to prove ICI’s work as they already have approval.
Unless I’m missing something ????